Santen Pharmaceutical Co Ltd 2025 Sustainability Report
The report presents Santen's FY2024 sustainability performance across consolidated environmental, social, and governance data. Highlights include 34,870 t-CO2 of Scope 1 and market-based Scope 2 emissions, 154,563 tons of partial Scope 3 emissions, and a 99.6% group non-landfill disposal rate. The Group reports 3,849 employees, 40.5% women in managerial positions on a consolidated basis, and zero work-related fatalities. Santen also reports a 50% Scope 1 and 2 reduction target by 2030 and a net-zero ambition for 2050.
Company: Santen Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2025
Type: Sustainability Report
Pages: 109
Back to company
Santen Pharmaceutical Co Ltd
Sustainability Report
The report presents Santen's FY2024 sustainability performance across consolidated environmental, social, and governance data. Highlights include 34,870 t-CO2 of Scope 1 and market-based Scope 2 emissions, 154,563 tons of partial Scope 3 emissions, and a 99.6% group non-landfill disposal rate. The Group reports 3,849 employees, 40.5% women in managerial positions on a consolidated basis, and zero work-related fatalities. Santen also reports a 50% Scope 1 and 2 reduction target by 2030 and a net-zero ambition for 2050.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Apr 1, 2024 - Mar 31, 2025
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees